Elliott J Brea

7PUBLICATIONS
92CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

|Aug 03, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy.

Peter G Miller, Adam S Sperling, Elliott J Brea

|Jul 13, 2021
A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment.

Elliott J Brea, Bruce C Tiu, Jean M Connors

|Sep 22, 2019
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.

Claire Y Oh, Martin G Klatt, Christopher Bourne

Pageof 2

Frequent Collaborators

2 joint publications

Sachiv Chakravarti

2 joint publications

Elena V Ivanova

2 joint publications

Marie-Anais Locquet

2 joint publications

Conor Hinchey